Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cis association of leukocyte Ig‐like receptor 1 with MHC class I modulates accessibility to antibodies and HCMV UL18
Nicholas L. Li, Li Fu, Hannes Uchtenhagen, et al.
European Journal of Immunology (2013) Vol. 43, Iss. 4, pp. 1042-1052
Closed Access | Times Cited: 21

Showing 21 citing articles:

On the Way to Become a Natural Killer Cell
Clara Di Vito, Joanna Mikulak, Domenico Mavilio
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 80
CMV and natural killer cells: shaping the response to vaccination
Martin R. Goodier, Stipan Jonjić, Eleanor M. Riley, et al.
European Journal of Immunology (2017) Vol. 48, Iss. 1, pp. 50-65
Open Access | Times Cited: 75
Leukocyte Ig-Like Receptors – A Model for MHC Class I Disease Associations
Laura Emily Hudson, Rachel Allen
Frontiers in Immunology (2016) Vol. 7
Open Access | Times Cited: 70
Cell-Extrinsic MHC Class I Molecule Engagement Augments Human NK Cell Education Programmed by Cell-Intrinsic MHC Class I
Jeanette E. Boudreau, Xiaorong Liu, Zeguo Zhao, et al.
Immunity (2016) Vol. 45, Iss. 2, pp. 280-291
Open Access | Times Cited: 69
Leukocyte Immunoglobulin-Like Receptors in Regulating the Immune Response in Infectious Diseases: A Window of Opportunity to Pathogen Persistence and a Sound Target in Therapeutics
Florence Abdallah, Sixtine Coindre, Margaux Gardet, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 41
The MHC class I‐LILRB1 signalling axis as a promising target in cancer therapy
Jinming Zhao, Shanshan Zhong, Xing Niu, et al.
Scandinavian Journal of Immunology (2019) Vol. 90, Iss. 5
Open Access | Times Cited: 43
Education of Murine NK Cells Requires Both cis and trans Recognition of MHC Class I Molecules
Stéphanie Bessoles, Georgi S. Angelov, Jonathan Back, et al.
The Journal of Immunology (2013) Vol. 191, Iss. 10, pp. 5044-5051
Open Access | Times Cited: 47
Strategies for Genetically Engineering Hypoimmunogenic Universal Pluripotent Stem Cells
Wei Zhao, Anhua Lei, Lin Tian, et al.
iScience (2020) Vol. 23, Iss. 6, pp. 101162-101162
Open Access | Times Cited: 38
Tumor-Associated Macrophage Targeting of Nanomedicines in Cancer Therapy
Xuejia Kang, Yongzhuo Huang, Huiyuan Wang, et al.
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 61-61
Open Access | Times Cited: 12
The Expanding Spectrum of Ligands for Leukocyte Ig-like Receptors
Deborah N. Burshtyn, Chris Morcos
The Journal of Immunology (2016) Vol. 196, Iss. 3, pp. 947-955
Open Access | Times Cited: 35
Selection, tuning, and adaptation in mouse NK cell education
Nadir Kadri, Thuy Luu Thanh, Petter Höglund
Immunological Reviews (2015) Vol. 267, Iss. 1, pp. 167-177
Closed Access | Times Cited: 33
LILRB1 polymorphisms influence posttransplant HCMV susceptibility and ligand interactions
Kang Yu, Chelsea L. Davidson, Agnieszka Wójtowicz, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 4, pp. 1523-1537
Open Access | Times Cited: 27
Ly49C-Dependent Control of MCMV Infection by NK Cells Is Cis-Regulated by MHC Class I Molecules
Catherine A. Forbes, Anthony A. Scalzo, Mariapia A. Degli‐Esposti, et al.
PLoS Pathogens (2014) Vol. 10, Iss. 5, pp. e1004161-e1004161
Open Access | Times Cited: 26
Tuning of human NK cells by endogenous HLA-C expression
Frederick J. Goodson-Gregg, Stacey A Krepel, Stephen K. Anderson
Immunogenetics (2020) Vol. 72, Iss. 4, pp. 205-215
Open Access | Times Cited: 22
Interaction of the LILRB1 inhibitory receptor with HLA class Ia dimers
Diogo Baía, Jordi Pou, Des C. Jones, et al.
European Journal of Immunology (2016) Vol. 46, Iss. 7, pp. 1681-1690
Open Access | Times Cited: 21
KIR3DL01 upregulation on gut natural killer cells in response to SIV infection of KIR- and MHC class I-defined rhesus macaques
Moritz Ries, Matthew R. Reynolds, Ksenia Bashkueva, et al.
PLoS Pathogens (2017) Vol. 13, Iss. 7, pp. e1006506-e1006506
Open Access | Times Cited: 16
MHC-I Molecules Selectively Inhibit Cell-Mediated Cytotoxicity Triggered by ITAM-Coupled Activating Receptors and 2B4
Rubén Corral-San-Miguel, Trinidad Hernández‐Caselles, Antonio J. Ruiz‐Alcaraz, et al.
PLoS ONE (2014) Vol. 9, Iss. 9, pp. e107054-e107054
Open Access | Times Cited: 3
Mechanisms regulating NK cell activation during viral infection
Catherine A. Forbes, Jérôme D. Coudert
Future Virology (2015) Vol. 10, Iss. 2, pp. 135-154
Open Access
Investigating the role of the D0 domain of KIR3DL1 in ligand interaction and exploring the effect of LILRB1 on KIR3DL1 signaling
Li Fu
(2013)
Closed Access
The Role of Leukocyte Immunoglobulin-Like Receptors Focusing on the Therapeutic Implications of the Subfamily B2
Feng Feng, Haopeng Sun, Yanyu Hu, et al.
Current Drug Targets (2022) Vol. 23, Iss. 15, pp. 1430-1452
Open Access
Page 1

Scroll to top